Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study
Aim:This study investigated the potential role of serum copeptin, a mediator of acute pain via sympathetic stress stimulation, as a biomarker of varying degrees of migraine-related disability. Specifically, we aimed to analyze whether the serum copeptin level can be used to differentiate migraine ty...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2023-09-01
|
| Series: | Haseki Tıp Bülteni |
| Subjects: | |
| Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/serum-copeptin-levels-in-adult-patients-with-a-mig/62245
|
| _version_ | 1797672333216841728 |
|---|---|
| author | Ilker Eski Ozgur Sogut Ozgur Deniz Sadioglu Sumeyye Cakmak Huseyin Ergenc Onur Kaplan |
| author_facet | Ilker Eski Ozgur Sogut Ozgur Deniz Sadioglu Sumeyye Cakmak Huseyin Ergenc Onur Kaplan |
| author_sort | Ilker Eski |
| collection | DOAJ |
| description | Aim:This study investigated the potential role of serum copeptin, a mediator of acute pain via sympathetic stress stimulation, as a biomarker of varying degrees of migraine-related disability. Specifically, we aimed to analyze whether the serum copeptin level can be used to differentiate migraine types (e.g., with and without aura).Methods:The study population included 80 consecutively consenting adult patients who had migraine attacks and attended the emergency department from June 2020 through November 2020, as well as 80 age- and sex-matched healthy controls. Using the Migraine Disability Assessment Scale (MIDAS), the same medical professional assessed each patient’s level of headache-related disability. Based on their MIDAS scores, the patients were separated into four groups: no disability (score 0-5; group MIDAS-I); mild disability (score 6-10; group MIDAS-II); moderate impairment (score 11-20; group MIDAS-III); and severe disability (score >20; group MIDAS-IV). There were also two categories of migraineurs: those with auras and those without auras. Upon admission, comparisons were made between the groups’ serum copeptin values.Results:In comparison to the control group, the patient group’s serum copeptin levels were noticeably higher (2113.30±206.20 vs. 1383.40±488.40; p<0.001). The study of the receiving operator’s characteristics showed that the cut-off copeptin level was 1898.5 pg/mL, with 90% sensitivity and 82.4% specificity for distinguishing patients from controls. There were no noticeable differences in the mean serum copeptin levels between the patient groups when compared by MIDAS score. Additionally, patients with and without aura did not differ notably in terms of mean serum copeptin levels. (2118.70±211.60 vs. 2071.10±160.40).Conclusion:Serum copeptin levels may be used as a diagnostic aid to help anticipate migraine-related headache attacks when combined with clinical signs and symptoms. |
| first_indexed | 2024-03-11T21:28:26Z |
| format | Article |
| id | doaj.art-0b61432feb3b40d7a3ce652f3358d38b |
| institution | Directory Open Access Journal |
| issn | 1302-0072 2147-2688 |
| language | English |
| last_indexed | 2024-03-11T21:28:26Z |
| publishDate | 2023-09-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Haseki Tıp Bülteni |
| spelling | doaj.art-0b61432feb3b40d7a3ce652f3358d38b2023-09-27T13:15:53ZengGalenos YayineviHaseki Tıp Bülteni1302-00722147-26882023-09-0161428028510.4274/haseki.galenos.2023.889913049054Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional StudyIlker Eski0Ozgur Sogut1Ozgur Deniz Sadioglu2Sumeyye Cakmak3Huseyin Ergenc4Onur Kaplan5 University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Emergency Medicine, Istanbul, Turkey University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Emergency Medicine, Istanbul, Turkey University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Emergency Medicine, Istanbul, Turkey University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Emergency Medicine, Istanbul, Turkey University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Emergency Medicine, Istanbul, Turkey University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Clinic of Emergency Medicine, Istanbul, Turkey Aim:This study investigated the potential role of serum copeptin, a mediator of acute pain via sympathetic stress stimulation, as a biomarker of varying degrees of migraine-related disability. Specifically, we aimed to analyze whether the serum copeptin level can be used to differentiate migraine types (e.g., with and without aura).Methods:The study population included 80 consecutively consenting adult patients who had migraine attacks and attended the emergency department from June 2020 through November 2020, as well as 80 age- and sex-matched healthy controls. Using the Migraine Disability Assessment Scale (MIDAS), the same medical professional assessed each patient’s level of headache-related disability. Based on their MIDAS scores, the patients were separated into four groups: no disability (score 0-5; group MIDAS-I); mild disability (score 6-10; group MIDAS-II); moderate impairment (score 11-20; group MIDAS-III); and severe disability (score >20; group MIDAS-IV). There were also two categories of migraineurs: those with auras and those without auras. Upon admission, comparisons were made between the groups’ serum copeptin values.Results:In comparison to the control group, the patient group’s serum copeptin levels were noticeably higher (2113.30±206.20 vs. 1383.40±488.40; p<0.001). The study of the receiving operator’s characteristics showed that the cut-off copeptin level was 1898.5 pg/mL, with 90% sensitivity and 82.4% specificity for distinguishing patients from controls. There were no noticeable differences in the mean serum copeptin levels between the patient groups when compared by MIDAS score. Additionally, patients with and without aura did not differ notably in terms of mean serum copeptin levels. (2118.70±211.60 vs. 2071.10±160.40).Conclusion:Serum copeptin levels may be used as a diagnostic aid to help anticipate migraine-related headache attacks when combined with clinical signs and symptoms. http://www.hasekidergisi.com/archives/archive-detail/article-preview/serum-copeptin-levels-in-adult-patients-with-a-mig/62245 copeptinmigrainebiomarkerheadache |
| spellingShingle | Ilker Eski Ozgur Sogut Ozgur Deniz Sadioglu Sumeyye Cakmak Huseyin Ergenc Onur Kaplan Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study Haseki Tıp Bülteni copeptin migraine biomarker headache |
| title | Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study |
| title_full | Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study |
| title_fullStr | Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study |
| title_full_unstemmed | Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study |
| title_short | Serum Copeptin Levels in Adult Patients with a Migraine Attack: A Cross-Sectional Study |
| title_sort | serum copeptin levels in adult patients with a migraine attack a cross sectional study |
| topic | copeptin migraine biomarker headache |
| url |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/serum-copeptin-levels-in-adult-patients-with-a-mig/62245
|
| work_keys_str_mv | AT ilkereski serumcopeptinlevelsinadultpatientswithamigraineattackacrosssectionalstudy AT ozgursogut serumcopeptinlevelsinadultpatientswithamigraineattackacrosssectionalstudy AT ozgurdenizsadioglu serumcopeptinlevelsinadultpatientswithamigraineattackacrosssectionalstudy AT sumeyyecakmak serumcopeptinlevelsinadultpatientswithamigraineattackacrosssectionalstudy AT huseyinergenc serumcopeptinlevelsinadultpatientswithamigraineattackacrosssectionalstudy AT onurkaplan serumcopeptinlevelsinadultpatientswithamigraineattackacrosssectionalstudy |